Skip to main content

Table 6 Risk stratification in the validation cohort

From: A novel tool for predicting the risk of central lymph node metastasis in patients with papillary thyroid microcarcinoma: a retrospective cohort study

 

count

M

SD

Min

Max

Q2

Q1

Q3

Validation cohort

Low-score-risk

53

106.9

32.13

36.88

146.56

112.04

76.03

140.51

Medium-score- risk

72

199.12

32.37

151.2

251.2

188.08

175.16

237.59

High-score- risk

39

315.82

43

266.19

413.62

316.55

274.46

342.22